S Marousi, E Giannouli, I Karkanis, G A Tagaris, C E Karageorgiou. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedHumansImmune Reconstitution Inflammatory Syndrome/chemically inducedNatalizumabSubstance Withdrawal Syndrome
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedNatalizumab
Year: 2011 PMID: 21618740
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910